Does DALFAMPRIDINE Cause Product distribution issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product distribution issue have been filed in association with DALFAMPRIDINE (Dalfampridine). This represents 0.0% of all adverse event reports for DALFAMPRIDINE.
6
Reports of Product distribution issue with DALFAMPRIDINE
0.0%
of all DALFAMPRIDINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product distribution issue From DALFAMPRIDINE?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DALFAMPRIDINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DALFAMPRIDINE Cause?
Gait disturbance (8,780)
Drug ineffective (6,794)
Fall (5,554)
Therapy cessation (4,580)
Fatigue (3,778)
Balance disorder (3,753)
Multiple sclerosis relapse (3,322)
Condition aggravated (3,240)
Dizziness (2,959)
Urinary tract infection (2,757)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which DALFAMPRIDINE Alternatives Have Lower Product distribution issue Risk?
DALFAMPRIDINE vs DALTEPARIN
DALFAMPRIDINE vs DAMOCTOCOG ALFA PEGOL
DALFAMPRIDINE vs DANAPAROID
DALFAMPRIDINE vs DANAZOL
DALFAMPRIDINE vs DANICOPAN